Affiliation:
1. Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA 52242, USA
2. Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA 52242, USA
Abstract
Ribonucleotide reductase (RNR) is the rate-limiting enzyme in the synthesis of deoxyribonucleotides and the target of multiple chemotherapy drugs, including gemcitabine. We previously identified that inhibition of RNR in Ewing sarcoma tumors upregulates the expression levels of multiple members of the activator protein-1 (AP-1) transcription factor family, including c-Jun and c-Fos, and downregulates the expression of c-Myc. However, the broader functions and downstream targets of AP-1, which are highly context- and cell-dependent, are unknown in Ewing sarcoma tumors. Consequently, in this work, we used genetically defined models, transcriptome profiling, and gene-set -enrichment analysis to identify that AP-1 and EWS-FLI1, the driver oncogene in most Ewing sarcoma tumors, reciprocally regulate the expression of multiple extracellular-matrix proteins, including fibronectins, integrins, and collagens. AP-1 expression in Ewing sarcoma cells also drives, concurrent with these perturbations in gene and protein expression, changes in cell morphology and phenotype. We also identified that EWS-FLI1 dysregulates the expression of multiple AP-1 proteins, aligning with previous reports demonstrating genetic and physical interactions between EWS-FLI1 and AP-1. Overall, these results provide novel insights into the distinct, EWS-FLI1-dependent features of Ewing sarcoma tumors and identify a novel, reciprocal regulation of extracellular-matrix components by EWS-FLI1 and AP-1.
Funder
Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation
Holden Comprehensive Cancer Center at The University of Iowa
Reference68 articles.
1. Ewing’s Sarcoma;Balamuth;Lancet Oncol.,2010
2. Gene Fusion with an ETS DNA-Binding Domain Caused by Chromosome Translocation in Human Tumours;Delattre;Nature,1992
3. Ewing’s Sarcoma Family Tumors Are Sensitive to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Express Death Receptor 4 and Death Receptor 5;Mitsiades;Cancer Res.,2001
4. Ewing sarcoma;Surdez;Nat. Rev. Dis. Primers,2018
5. Stegmaier, K., Wong, J.S., Ross, K.N., Chow, K.T., Peck, D., Wright, R.D., Lessnick, S.L., Kung, A.L., and Golub, T.R. (2007). Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing sarcoma. PLoS Med., 4.